Simultaneous determination of matrine, oxysophocarpin and oxymatrine in rat plasma by HPLC-MS and its application in the pharmacokinetic study.
- Author:
Lei ZHANG
1
;
Zhi-Wei WANG
;
Jian-Wei LIAN
;
Hao ZHOU
;
Xiao-Hui CHEN
;
Kai-Shun BI
Author Information
1. College of Chinese Traditional Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510006, China.
- Publication Type:Journal Article
- MeSH:
Administration, Oral;
Alkaloids;
blood;
pharmacokinetics;
Animals;
Area Under Curve;
Chromatography, High Pressure Liquid;
methods;
Drug Combinations;
Drugs, Chinese Herbal;
isolation & purification;
pharmacokinetics;
Male;
Plants, Medicinal;
chemistry;
Quinolizines;
blood;
pharmacokinetics;
Rats;
Rats, Wistar;
Spectrometry, Mass, Electrospray Ionization;
methods
- From:
Acta Pharmaceutica Sinica
2008;43(8):843-847
- CountryChina
- Language:Chinese
-
Abstract:
To establish an HPLC-MS method for simultaneous determination of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of herbal preparation, namely Sanwu Huangqin decoction, and the pharmacokinetic porameters were calculated as well. Matrine, oxymatrine, oxysophocarpine, and internal standard pseudoephedrine were extracted from plasma with liquid-liquid extraction, then separated on a Kromasil C18 column by using acetonitrile-0.1% aqueous formic acid (10 : 90) as mobile phase. Electrospray ionization (ESI) source was applied and operated in positive ion mode. The linear calibration curve was obtained in the concentration range of 10 -5 000 ng x mL(-1) for matrine, 2 - 1 000 ng x mL(-1) for oxymatrine, and 2 - 1 000 ng x mL(-1) for oxysophocarpine. The extraction recovery was 89.1% - 93.5%, 83.9% - 91.3%, and 85.4% - 88.0% accordingly. The inter- and intra- day precision (RSD) was below 15.0% calculated from quality control (QC) samples. Matrine, oxymatrine and oxysophocarpine concentration time profile conformed to a two-compartment pharmacokinetic model. The method was shown to be effective, convenient, and suitable for simultaneous pharmacokinetic study of matrine, oxymatrine, and oxysophocarpine in rat.